DIRECTIONS OF DEVELOPMENT OF THE PROGRAM OF DRUG PROVISION FOR EXPENSIVE DISEASES
- Authors: Tolkushin A.G.1, Fedorov A.A.2, Zhulev U.A.3, Pogudina N.L.4, Ermolaeva T.N.1
-
Affiliations:
- Scientific-practical center of clinical research and health technology assessment, Healthcare Department of Moscow
- Institute of public and regulated procurement, competition policy and anticorruption technologies, Kutafin Moscow State Law University
- Russian Hemophilia Society
- Independent research company «Smart choice»
- Issue: Vol 63, No 5 (2019)
- Pages: 237-244
- Section: HEALTH CARE ORGANIZATION
- Submitted: 25.10.2024
- URL: https://rjsocmed.com/0044-197X/article/view/637642
- DOI: https://doi.org/10.18821/0044-197X-2019-63-5-237-244
- ID: 637642
Cite item
Full Text
Abstract
About the authors
A. G. Tolkushin
Scientific-practical center of clinical research and health technology assessment, Healthcare Department of Moscow
Author for correspondence.
Email: tolkushin@inbox.ru
Russian Federation
A. A. Fedorov
Institute of public and regulated procurement, competition policy and anticorruption technologies, Kutafin Moscow State Law University
Email: noemail@neicon.ru
Russian Federation
U. A. Zhulev
Russian Hemophilia Society
Email: noemail@neicon.ru
Russian Federation
N. L. Pogudina
Independent research company «Smart choice»
Email: noemail@neicon.ru
Russian Federation
T. N. Ermolaeva
Scientific-practical center of clinical research and health technology assessment, Healthcare Department of Moscow
Email: noemail@neicon.ru
Russian Federation
References
Supplementary files
